Market research
RTIX RTI Surgical Holdings, Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 234M
- P/E ratio
- Not available
- Analyst target
- 5.5
- Dividend yield
- 0.0%
- Beta
- 2.03
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US74975N1054
- Market cap
- 234M
- P/E ratio
- Not available
- Analyst target
- 5.5
- Dividend yield
- 0.0%
- Beta
- 2.03
About
About RTI Surgical Holdings, Inc
Surgalign Holdings, Inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the RTIX discussion.
5 years, 4 months ago
RTI Surgical Holdings, Inc is currently in a long term downtrend where the price is trading 27.1% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
RTI Surgical Holdings, Inc's total revenue sank by 63.3% to $28M since the same quarter in the previous year.
Its net income has increased by 2628.5% to $123M since the same quarter in the previous year.
Finally, its free cash flow fell by 1595.7% to $-61M since the same quarter in the previous year.
Based on the above factors, RTI Surgical Holdings, Inc gets an overall score of 2/5.